Biositu is a high-tech company based on a stable and efficient gene editing technology platform, which integrates model animal customization services, important model animal development and large-scale reproduction and supply, in vivo pharmacology and efficacy evaluation services, and antibody drug R&D outsourcing services. Biopharmaceutical companies. It has a gene editing platform, a model animal reproduction and supply platform, a pharmacology and efficacy platform, and an antibody drug research and development service platform. Post-hearing documents submitted by Bioceitu HKEx today.
This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E7%99%BE%E5%A5%A5%E8%B5%9B%E5%9B%BE
This site is for inclusion only, and the copyright belongs to the original author.